Albireo Pharma, Inc.
ALBODelisted Mar 2, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001322505
Albireo Pharma, Inc. was delisted on Mar 2, 2023; its insiders filed their last Form 4 on Mar 3, 2023; 96 institutions reported holding it in 13F filings for Q4 2022, worth $401.7M in total; no superinvestor held it.
13F holders, Q3 2022
Institutional positions in Albireo Pharma, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 109
- +6 vs. Q2 2022
- Shares held
- 19.3M
- +1.44M (+8.1%) vs. Q2 2022
- Total value
- $372.0M
- +$19.5M (+5.5%) vs. Q2 2022
- New holders
- 22
- 45 more added
- Sold out
- 16
- 28 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ALBO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $44 |
| Q1 2026 | 1 | $44 |
| Q4 2025 | 1 | $44 |
| Q3 2025 | 1 | $744 |
| Q2 2025 | 1 | $744 |
| Q1 2025 | 1 | $744 |
| Q4 2024 | 1 | $744 |
| Q3 2024 | 1 | $744 |
| Q2 2024 | 1 | $744 |
| Q1 2024 | 1 | $744 |
| Q4 2023 | 1 | $744 |
| Q3 2023 | 1 | $744 |
| Q2 2023 | 1 | $756 |
| Q1 2023 | 3 | $2.04M |
| Q4 2022 | 96 | $401.7M |
| Q3 2022 | 109 | $372.0M |
| Q2 2022 | 103 | $352.6M |
| Q1 2022 | 109 | $495.4M |
| Q4 2021 | 96 | $362.5M |
| Q3 2021 | 94 | $477.0M |
| Q2 2021 | 99 | $546.1M |
| Q1 2021 | 100 | $589.8M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Albireo Pharma, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| ArrowMark Colorado Holdings LLC | 791,249 | $15.3M | 0.19% | +184,286+30.4% | Added |
| Vanguard Group Inc | 917,480 | $17.8M | 0.00% | −76,490−7.7% | Reduced |
| Franklin Resources Inc | 925,304 | $17.9M | 0.01% | +52,406+6.0% | Added |
| Tang Capital Management LLC | 1,099,516 | $21.3M | 2.61% | +399,516+57.1% | Added |
| Deep Track Capital, LP | 1,110,624 | $21.5M | 1.06% | +1,110,624 | New |
| Chicago Capital, LLC | 1,119,774 | $21.7M | 1.25% | −231,460−17.1% | Reduced |
| BlackRock Inc. | 1,215,406 | $23.5M | 0.00% | +2,786+0.2% | Added |
| Federated Hermes, Inc. | 2,258,124 | $43.7M | 0.13% | +3,000+0.1% | Added |
| Perceptive Advisors LLC | 2,360,139 | $45.7M | 1.33% | 00.0% | Unchanged |
| Nicholas Investment Partners, LP | 0 | $0 | 0.00% | −430,878−100.0% | Sold out |
| J. Goldman & Co LP | 0 | $0 | 0.00% | −231,278−100.0% | Sold out |
| Sio Capital Management, LLC | 0 | $0 | 0.00% | −58,556−100.0% | Sold out |
| Rafferty Asset Management, LLC | 0 | $0 | 0.00% | −57,758−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −54,015−100.0% | Sold out |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −30,401−100.0% | Sold out |
| Victory Capital Management Inc | 0 | $0 | 0.00% | −22,380−100.0% | Sold out |
| Martingale Asset Management L P | 0 | $0 | 0.00% | −19,407−100.0% | Sold out |
| CSS LLC | 0 | $0 | 0.00% | −12,143−100.0% | Sold out |
| Gsa Capital Partners LLP | 0 | $0 | 0.00% | −10,079−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −4,300−100.0% | Sold out |
| Steward Partners Investment Advisory, LLC | 0 | $0 | 0.00% | −900−100.0% | Sold out |
| Curi Capital | 0 | $0 | 0.00% | −163−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −115−100.0% | Sold out |
| Glassman Wealth Services | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| Parallel Advisors, LLC | 0 | $0 | 0.00% | −9−100.0% | Sold out |